Back to 
JANE STREET GROUP, LLC
JANE STREET GROUP, LLC
NBRVShowing 0 of 6 quarters
Position history for JANE STREET GROUP, LLC's holdings in NABRIVA THERAPEUTICS PLC
No. Jane Street Group exited its NBRV (Nabriva Therapeutics) position in Q3 2022. Its Q2 2022 13F listed 66,388 shares worth $12,000. Jane Street Group first reported NBRV in Q1 2021 and held it in 3 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of NBRV: FMR LLC, RENAISSANCE TECHNOLOGIES LLC